Chemical Communications,
Journal Year:
2024,
Volume and Issue:
60(93), P. 13641 - 13652
Published: Jan. 1, 2024
Hypoxia
limits
the
phototherapeutic
efficacy
of
porphyrin-based
nMOFs;
loading
with
hypoxia-activated
drug
TPZ
enhances
combined
PDT
and
chemotherapy
effects.
Pharmaceutical Development and Technology,
Journal Year:
2024,
Volume and Issue:
29(3), P. 221 - 235
Published: Feb. 26, 2024
Photodynamic
therapy
(PDT)
has
emerged
as
a
promising
non
invasive
therapeutic
approach
for
cancer
treatment,
offering
unique
advantages
over
conventional
treatments.
The
combination
of
light
activation
and
photosensitizing
agents
allows
targeted
localized
destruction
cells,
reducing
damage
to
surrounding
healthy
tissues.
In
recent
years,
the
integration
nanoparticles
with
PDT
garnered
significant
attention
due
their
potential
enhance
outcomes.
This
review
article
aims
provide
comprehensive
overview
current
state-of-the-art
in
utilizing
photodynamic
treatment.
We
summarized
various
nanoparticle-based
approaches,
properties,
implications
optimizing
efficacy,
discussed
challenges
prospects
field.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
177, P. 117118 - 117118
Published: July 14, 2024
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
prevalent
malignant
tumors
in
contemporary
era,
representing
a
significant
global
health
concern.
Early
HCC
patients
have
mild
symptoms
or
are
asymptomatic,
which
promotes
onset
and
progression
disease.
Moreover,
advanced
insensitive
to
chemotherapy,
making
traditional
clinical
treatment
unable
block
cancer
development.
Sorafenib
(SFB)
first-line
targeted
drug
for
with
anti-angiogenesis
anti-tumor
cell
proliferation
effects.
However,
efficacy
SFB
constrained
by
its
off-target
distribution,
rapid
metabolism,
multi-drug
resistance.
In
recent
years,
nanoparticles
based
on
variety
materials
been
demonstrated
enhance
targeting
therapeutic
against
HCC.
Concurrently,
advent
joint
delivery
systems
has
furnished
crucial
empirical
evidence
reversing
This
review
will
summarize
application
nanotechnology
field
over
past
five
years.
It
focus
research
progress
combined
multiple
modalities
treatment.
Chemical Communications,
Journal Year:
2024,
Volume and Issue:
60(73), P. 9938 - 9941
Published: Jan. 1, 2024
Nanoparticles
incorporating
an
Ir(
iii
)
complex
are
photosensitisers
that
generate
types
I
and
II
reactive
oxygen
species
upon
655
nm
laser
irradiation
achieve
photodynamic
therapy
in
hypoxic
cancer
cells
by
targeting
mitochondria.
Chemical Communications,
Journal Year:
2024,
Volume and Issue:
60(93), P. 13641 - 13652
Published: Jan. 1, 2024
Hypoxia
limits
the
phototherapeutic
efficacy
of
porphyrin-based
nMOFs;
loading
with
hypoxia-activated
drug
TPZ
enhances
combined
PDT
and
chemotherapy
effects.